Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Csl Ltd ADR (CSLLY)

Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 94,301,888
  • Shares Outstanding, K 966,505
  • Annual Sales, $ 13,310 M
  • Annual Income, $ 2,194 M
  • 60-Month Beta 0.77
  • Price/Sales 7.05
  • Price/Cash Flow 30.96
  • Price/Book 5.25
Trade CSLLY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/27/23
  • Annual Dividend & Yield 1.14 (1.17%)
  • Most Recent Dividend 0.545 on 03/11/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.6100 +6.94%
on 05/29/24
99.5100 -1.55%
on 06/20/24
+4.5000 (+4.81%)
since 05/24/24
3-Month
85.9600 +13.97%
on 04/22/24
99.5100 -1.55%
on 06/20/24
+6.4900 (+7.09%)
since 03/22/24
52-Week
71.5100 +37.00%
on 10/30/23
99.9500 -1.98%
on 12/27/23
+3.7100 (+3.94%)
since 06/23/23

Most Recent Stories

More News
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...

CSL : 426.43 (+2.21%)
CSLLY : 97.9700 (+0.41%)
Why CSL Ltd Stock Could Be Worth a Look

FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.

CSL : 426.43 (+2.21%)
CSLLY : 97.9700 (+0.41%)
NVS : 106.95 (+1.64%)
BLUE : 1.0200 (+13.45%)
ARCT : 27.33 (-0.44%)
Why Arcturus Therapeutics Stock Is Skyrocketing Today

Investors are applauding Arcturus' collaboration with CSL.

CSL.AX : 293.700 (+0.58%)
CSLLY : 97.9700 (+0.41%)
ARCT : 27.33 (-0.44%)
Finalization of Vifor Pharma acquisition

Regulatory News:

CSL.AX : 293.700 (+0.58%)
OTC.VN : 0.300 (-3.23%)
CSLLY : 97.9700 (+0.41%)
uniQure announces closing of commercialization and license agreement with CSL Behring

Upfront payment of $450 million due to uniQure by May 13, 2021

CSLLY : 97.9700 (+0.41%)
ASX : 11.39 (-1.64%)
QURE : 4.54 (-1.09%)
The Latest: Mexico to lower virus alert level in many states

MEXICO CITY __ Mexico is reducing its COVID-19 alert level in about half of the country’s states amid a drop in infections and hospitalizations in many places, including the capital.

PFE : 28.36 (+2.24%)
CSL : 426.43 (+2.21%)
CSLLY : 97.9700 (+0.41%)
The Latest: Australia's 2nd largest city to begin lockdown

MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown due to a rapidly spreading COVID-19 cluster centered on hotel quarantine.

JNJ : 149.12 (+0.25%)
CSL : 426.43 (+2.21%)
CSLLY : 97.9700 (+0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CSL Ltd. is a biopharmaceutical company. It engages in researches, develops, manufactures and markets vaccines and plasma protein biotherapies to treat and prevent human medical conditions. The company's operating segments consists of CSL Behring and bioCSL. CSL Behring segment provides plasma-derived...

See More

Key Turning Points

3rd Resistance Point 98.8500
2nd Resistance Point 98.5100
1st Resistance Point 98.2400
Last Price 97.9700
1st Support Level 97.6300
2nd Support Level 97.2900
3rd Support Level 97.0200

See More

52-Week High 99.9500
Last Price 97.9700
Fibonacci 61.8% 89.0859
Fibonacci 50% 85.7300
Fibonacci 38.2% 82.3741
52-Week Low 71.5100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar